168 related articles for article (PubMed ID: 33135257)
1. Blood eosinophil count as predictor of asthma exacerbation. A meta-analysis.
Mallah N; Rodriguez-Segade S; Gonzalez-Barcala FJ; Takkouche B
Pediatr Allergy Immunol; 2021 Apr; 32(3):465-478. PubMed ID: 33135257
[TBL] [Abstract][Full Text] [Related]
2. High blood eosinophil count is a risk factor for future asthma exacerbations in adult persistent asthma.
Zeiger RS; Schatz M; Li Q; Chen W; Khatry DB; Gossage D; Tran TN
J Allergy Clin Immunol Pract; 2014; 2(6):741-50. PubMed ID: 25439366
[TBL] [Abstract][Full Text] [Related]
3. Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults.
Petsky HL; Li A; Chang AB
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD005603. PubMed ID: 28837221
[TBL] [Abstract][Full Text] [Related]
4. Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study.
Price DB; Rigazio A; Campbell JD; Bleecker ER; Corrigan CJ; Thomas M; Wenzel SE; Wilson AM; Small MB; Gopalan G; Ashton VL; Burden A; Hillyer EV; Kerkhof M; Pavord ID
Lancet Respir Med; 2015 Nov; 3(11):849-58. PubMed ID: 26493938
[TBL] [Abstract][Full Text] [Related]
5. Demographic and Clinical Characteristics of COPD Patients at Different Blood Eosinophil Levels in the UK Clinical Practice Research Datalink.
Landis S; Suruki R; Maskell J; Bonar K; Hilton E; Compton C
COPD; 2018 Apr; 15(2):177-184. PubMed ID: 29558236
[TBL] [Abstract][Full Text] [Related]
6. Blood eosinophil count, a marker of inhaled corticosteroid effectiveness in preventing COPD exacerbations in post-hoc RCT and observational studies: systematic review and meta-analysis.
Harries TH; Rowland V; Corrigan CJ; Marshall IJ; McDonnell L; Prasad V; Schofield P; Armstrong D; White P
Respir Res; 2020 Jan; 21(1):3. PubMed ID: 31900184
[TBL] [Abstract][Full Text] [Related]
7. Ability of Serum IgE Concentration to Predict Exacerbation Risk and Benralizumab Efficacy for Patients with Severe Eosinophilic Asthma.
Jackson DJ; Humbert M; Hirsch I; Newbold P; Garcia Gil E
Adv Ther; 2020 Feb; 37(2):718-729. PubMed ID: 31836949
[TBL] [Abstract][Full Text] [Related]
8. Effect of fixed-dose subcutaneous reslizumab on asthma exacerbations in patients with severe uncontrolled asthma and corticosteroid sparing in patients with oral corticosteroid-dependent asthma: results from two phase 3, randomised, double-blind, placebo-controlled trials.
Bernstein JA; Virchow JC; Murphy K; Maspero JF; Jacobs J; Adir Y; Humbert M; Castro M; Marsteller DA; McElhattan J; Hickey L; Garin M; Vanlandingham R; Brusselle G
Lancet Respir Med; 2020 May; 8(5):461-474. PubMed ID: 32066536
[TBL] [Abstract][Full Text] [Related]
9. Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies.
Ortega HG; Yancey SW; Mayer B; Gunsoy NB; Keene ON; Bleecker ER; Brightling CE; Pavord ID
Lancet Respir Med; 2016 Jul; 4(7):549-556. PubMed ID: 27177493
[TBL] [Abstract][Full Text] [Related]
10. The association between blood eosinophil count and benralizumab efficacy for patients with severe, uncontrolled asthma: subanalyses of the Phase III SIROCCO and CALIMA studies.
Goldman M; Hirsch I; Zangrilli JG; Newbold P; Xu X
Curr Med Res Opin; 2017 Sep; 33(9):1605-1613. PubMed ID: 28644104
[TBL] [Abstract][Full Text] [Related]
11. Effect of Inhaled Corticosteroids on Exacerbation of Asthma-COPD Overlap According to Different Diagnostic Criteria.
Jo YS; Hwang YI; Yoo KH; Kim TH; Lee MG; Lee SH; Shin KC; In KH; Yoon HK; Rhee CK;
J Allergy Clin Immunol Pract; 2020 May; 8(5):1625-1633.e6. PubMed ID: 31953230
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of blood eosinophils and exhaled nitric oxide in adults with mild asthma: a prespecified subgroup analysis of an open-label, parallel-group, randomised controlled trial.
Pavord ID; Holliday M; Reddel HK; Braithwaite I; Ebmeier S; Hancox RJ; Harrison T; Houghton C; Oldfield K; Papi A; Williams M; Weatherall M; Beasley R;
Lancet Respir Med; 2020 Jul; 8(7):671-680. PubMed ID: 32171064
[TBL] [Abstract][Full Text] [Related]
13. Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults.
Petsky HL; Kynaston JA; Turner C; Li AM; Cates CJ; Lasserson TJ; Chang AB
Cochrane Database Syst Rev; 2007 Apr; (2):CD005603. PubMed ID: 17443604
[TBL] [Abstract][Full Text] [Related]
14. Association Between Clinical Burden and Blood Eosinophil Counts in Asthma: Findings From a Korean Adult Asthma Cohort.
Kim MY; Jo EJ; Kim S; Kim MH; Jung JW; Kim JH; Moon JY; Kwon JW; Lee JH; Park CS; Jin HJ; Shin YS; Kim SH; Cho YJ; Park JW; Cho SH; Kim TB; Park HK
J Korean Med Sci; 2022 Feb; 37(7):e57. PubMed ID: 35191233
[TBL] [Abstract][Full Text] [Related]
15. Baseline blood eosinophil count as a predictor of treatment response to the licensed dose of mepolizumab in severe eosinophilic asthma.
Albers FC; Licskai C; Chanez P; Bratton DJ; Bradford ES; Yancey SW; Kwon N; Quirce S
Respir Med; 2019 Nov; 159():105806. PubMed ID: 31751853
[TBL] [Abstract][Full Text] [Related]
16. Blood eosinophil count correlates with severity of respiratory failure in life-threatening asthma and predicts risk of subsequent exacerbations.
Yii ACA; Tay TR; Puah SH; Lim HF; Li A; Lau P; Tan R; Neo LP; Chung KF; Koh MS
Clin Exp Allergy; 2019 Dec; 49(12):1578-1586. PubMed ID: 31310686
[TBL] [Abstract][Full Text] [Related]
17. Blood eosinophils and inhaled corticosteroids in patients with COPD: systematic review and meta-analysis.
Cheng SL
Int J Chron Obstruct Pulmon Dis; 2018; 13():2775-2784. PubMed ID: 30233168
[TBL] [Abstract][Full Text] [Related]
18. Sputum and blood eosinophils during corticosteroid treatment of acute exacerbations of asthma.
Baigelman W; Chodosh S; Pizzuto D; Cupples LA
Am J Med; 1983 Dec; 75(6):929-36. PubMed ID: 6650547
[TBL] [Abstract][Full Text] [Related]
19. Relationship of Inhaled Corticosteroid Adherence to Asthma Exacerbations in Patients with Moderate-to-Severe Asthma.
Papi A; Ryan D; Soriano JB; Chrystyn H; Bjermer L; Rodríguez-Roisin R; Dolovich MB; Harris M; Wood L; Batsiou M; Thornhill SI; Price DB
J Allergy Clin Immunol Pract; 2018; 6(6):1989-1998.e3. PubMed ID: 29627457
[TBL] [Abstract][Full Text] [Related]
20. Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma.
Katz LE; Gleich GJ; Hartley BF; Yancey SW; Ortega HG
Ann Am Thorac Soc; 2014 May; 11(4):531-6. PubMed ID: 24606022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
